MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics today announced its participation in two upcoming conferences. Allegro Diagnostics is developing a molecular testing platform utilizing gene expression of normal epithelial cells in the respiratory tract to detect early signs of lung cancer.
